177Lu-P17-088
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 177Lu-P17-088, covering 2025-10-03 to 2025-10-03. Get the full timeline:
Most recent: Clinical Trial Update: 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer [EARLY_Phase 1]